Japan's switch to generic drugs from brand-name drugs is expected to have reduced medical costs by ¥1.3 trillion in fiscal 2017, the health ministry said Monday. The reduction, the biggest on record, would be about 40 percent larger than estimated for fiscal 2015. The government aims ...